2C-E (2,5-dimethoxy-4-ethylphenethylamine) is a psychedelic phenethylamine of the 2C family synthesized and characterized by Alexander Shulgin and documented in PiHKAL (1991). It is widely regarded as one of the most intellectually and psychologically demanding members of the 2C series — a compound that experienced psychedelic users approach with respect and that community members consistently describe as the "philosopher's drug" of the 2C family. At common doses (12–22 mg), 2C-E produces a 6–10 hour psychedelic experience of unusual depth and analytical character.
The defining feature of 2C-E relative to its siblings is the presence of a 4-ethyl substituent — an unusual chain group rather than a halogen at the C4 position. This structural feature appears to produce a distinct pharmacological signature: lower potency than 2C-B or 2C-I at equivalent doses, a substantially longer duration, significant mental stimulation and analytical thinking, a marked tendency toward introspection and philosophical inquiry, and pronounced nausea during the come-up. Community members frequently compare it to a "thinking man's psychedelic" — less visually spectacular than 2C-B but producing cognitive and emotional depth that many find more valuable for inner work.
2C-E also has a reputation within the harm reduction community for occasionally producing challenging or difficult experiences even at moderate doses — a property correlated with its intellectually demanding and emotionally penetrating character. The music community has noted 2C-E as exceptional for experiencing music analytically and emotionally, with a particularly intense appreciation for complex harmonic structures. Nausea during the initial 1–2 hours is common enough to be considered predictable; ginger preparations are a widely adopted harm reduction practice.
Safety at a Glance
High Risk- Respect the Reputation
- Threshold: 5–10 mg | Common: 15–20 mg | Strong: 20–25 mg | Heavy: 25+ mg
- Toxicity: General Safety Profile 2C-E has no reported fatalities attributable directly to its pharmacological action. However, ...
- Overdose risk: Fatal overdose from 2C-E alone, at doses within the typical recreational range, is extremely unli...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
insufflated
Duration
oral
Total: 6 hrs – 10 hrsinsufflated
Total: 5.1 hrs – 10.1 hrsHow It Feels
The onset is slow and deceptive, and this is where the difficulty often begins. Forty-five minutes to an hour may pass with only a faint nausea and a vague sense of unease to show for it. The stomach churns -- 2C-E is notorious for gastrointestinal discomfort, and the come-up nausea can be intense enough to overshadow the first hour of the experience. Then, without the gradual escalation that most psychedelics provide, the full force of the substance seems to arrive all at once. What was a faint shimmer in the visual field becomes a torrent of perceptual distortion that can feel genuinely overwhelming.
At the peak, 2C-E reveals itself as one of the most analytically intense members of the 2C family. The visual effects are strong and distinctive -- densely layered geometric patterns with a mechanical, almost architectural quality. Straight lines seem to vibrate and multiply. Surfaces become impossibly detailed, revealing layer upon layer of texture and structure that the sober eye completely ignores. Colors are vivid but lean toward cool, precise tones rather than the warm saturations of 2C-B. Closed-eye visuals present as vast, complex structures -- cathedrals of geometry that the mind seems compelled to explore and analyze rather than simply witness.
The cognitive component is formidable. Thought patterns become deeply analytical and relentlessly probing. The mind turns inward with an almost surgical precision, examining emotions, memories, and psychological structures with a clarity that can be illuminating or deeply uncomfortable depending on what it finds. There is a forceful quality to the introspection -- the substance does not gently invite reflection, it demands it. Emotional amplification is significant, and difficult feelings that surface cannot easily be pushed aside or distracted away from. The body load is heavy throughout: persistent nausea, muscle tension, occasional cramps, and a stimulant energy that makes relaxation difficult. The experience has earned its reputation for difficulty honestly -- it asks a great deal and does not soften its requests.
The peak can last three to five hours, and total effects extend seven to ten hours. The descent is gradual, with the visual intensity slowly diminishing while the analytical headspace persists. The aftermath often includes significant fatigue, residual gastrointestinal discomfort, and a feeling of having been thoroughly examined from the inside. But for many who weather the difficulty, there is also a sense of having gained genuine insight -- as though the substance forced an honest accounting that, however painful, was ultimately valuable.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(16)
- Bodily control enhancement— Bodily control enhancement is the subjective feeling of improved physical precision, coordination, a...
- Body load— A diffuse, heavy physical discomfort involving tension, pressure, and malaise in the torso and limbs...
- Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
- Frequent urination— Increased urinary frequency beyond normal patterns, caused by diuretic effects or bladder irritation...
- Increased blood pressure— Increased blood pressure (hypertension) is an elevation of arterial pressure above the normal 120/80...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Muscle tension— Persistent partial contractions or tightening of muscles that produces uncomfortable stiffness, cram...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Physical fatigue— Physical fatigue is a state of bodily exhaustion characterized by reduced energy, diminished capacit...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
- Temperature regulation disruption— Impaired thermoregulation causing unpredictable fluctuations between feeling hot and cold, with risk...
Tactile(1)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
Cognitive & Perceptual Effects
Visual(14)
- After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
- Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
- Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Pattern recognition enhancement— An increased ability and tendency to perceive meaningful patterns, faces, and images within ambiguou...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Scenery slicing— The visual field fractures into distinct, cleanly cut sections that slowly drift apart from their or...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
- Visual acuity enhancement— Vision becomes sharper and more defined than normal, as though a slightly blurry lens has been broug...
Cognitive(17)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Creativity enhancement— An increase in the ability to imagine new ideas, overcome creative blocks, think about existing conc...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Introspection— An enhanced state of self-reflective awareness in which one feels drawn to examine their own thought...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Novelty enhancement— A feeling of increased fascination, awe, and childlike wonder attributed to everyday concepts, objec...
- Personal bias suppression— A decrease in the personal, cultural, and cognitive biases through which one normally filters their ...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought connectivity— A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconne...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Multi-sensory(3)
- Machinescapes— Machinescapes are complex multisensory hallucinations involving the perception of enormous mechanica...
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
- Synaesthesia— Stimulation of one sense triggers involuntary experiences in another — seeing sounds as colors, tast...
Transpersonal(4)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
- Existential self-realization— A sudden, visceral realization of the profound significance and improbability of one's own existence...
- Spirituality enhancement— A profound intensification of spiritual feelings, mystical awareness, and a sense of sacred connecti...
- Unity and interconnectedness— A profound sense that identity extends beyond the self to encompass other people, nature, or all of ...
Pharmacology
Mechanism of Action
2C-E acts as a partial agonist at serotonin 5-HT2A receptors, sharing the primary mechanism of all classical psychedelics. Notably, among 2C family members, 2C-E is the least potent G-protein activator — its ethyl substituent at C4 reduces efficacy at the Gq-protein signaling pathway relative to halogen-substituted analogs. This lower intrinsic efficacy may contribute to the compound's qualitative distinctiveness despite producing robust psychedelic effects at higher doses.
Additional Receptor Activity
2C-E also binds to 5-HT2B and 5-HT2C receptors, consistent with the 2C family pattern. The relatively weak stimulant character compared to 2C-I or 2C-P may reflect the reduced transporter activity of the alkyl-substituted compound. The long duration (6–10 hours) is one of the longest in the 2C series excluding 2C-P, which may reflect the metabolic stability of the ethyl group compared to the more readily oxidized methyl or halogen groups.
Why It Differs from 2C-B
The pharmacological difference between 2C-E (ethyl at C4) and 2C-B (bromo at C4) produces a qualitatively distinct experience despite similar mechanisms. The ethyl group's different steric and electronic influence on 5-HT2A engagement appears to produce what users describe as a more "analytical," "emotionally penetrating" experience with less visual spectacle and more cognitive content. Structure-activity research has confirmed that alkyl substituents at C4 produce a different phenotype than halogen substituents, even at equivalent receptor occupancy levels.
Nausea
The pronounced nausea associated with 2C-E's come-up period is well-documented and appears to exceed that of other 2C compounds. The pharmacological basis is not fully established but may involve 5-HT3 agonism or peripheral 5-HT2 activity in the gastrointestinal tract.
Detection Methods
Urine Detection
2C-E is not specifically targeted by standard immunoassay-based urine drug panels. However, because 2C-x phenethylamines share structural features with amphetamines, they may trigger false positives on amphetamine immunoassays in some cases. The likelihood of cross-reactivity depends on the specific immunoassay manufacturer and the antibody selectivity used. Urine detection windows for 2C-E are estimated at 24 to 72 hours following ingestion when analyzed by LC-MS/MS methods, though limited pharmacokinetic data exists for many 2C-x compounds.
Blood and Serum Detection
Blood detection windows for 2C-E are approximately 6 to 24 hours after oral administration. Peak plasma concentrations typically occur 1 to 3 hours post-ingestion. The relatively short half-lives of most 2C-x phenethylamines mean that blood testing must be performed promptly to capture detectable concentrations. LC-MS/MS is the only reliable method for quantitative blood analysis.
Standard Drug Panel Inclusion
2C-E is NOT specifically included on standard 5-panel, 10-panel, or 12-panel drug screens. The primary concern for individuals undergoing routine screening is the potential for amphetamine cross-reactivity on immunoassay-based panels. If a presumptive positive for amphetamines occurs, confirmatory testing by GC-MS or LC-MS/MS would not confirm amphetamine and the result would be reported as negative unless the laboratory specifically tests for 2C-x compounds. Most routine laboratories do not include 2C-x phenethylamines in their confirmatory panels.
Confirmatory Methods
Definitive identification of 2C-E requires LC-MS/MS or GC-MS with appropriate reference standards. Some forensic toxicology laboratories include 2C-x phenethylamines in their extended novel psychoactive substance panels. Immunoassay cross-reactivity alone is insufficient for confirmation and would be resolved by standard confirmatory procedures. Quantitative analysis typically requires specific method development as these compounds are not part of routine clinical chemistry workflows.
Reagent Testing (Harm Reduction)
For harm reduction identification, the Marquis reagent is a primary screening tool for 2C-E. The Marquis reagent produces a dark green reaction with 2C-E that may darken to near-black over time. The Mecke reagent may provide additional color reactions that help differentiate between specific 2C-x variants. The Ehrlich reagent shows no reaction with 2C-x phenethylamines, which can help distinguish them from tryptamines and lysergamides. The Mandelin reagent may produce green to brown reactions depending on the specific compound. Using multiple reagents in combination provides the most reliable field identification, though reagent testing cannot determine purity or dosage.
Interactions
| Substance | Status | Note |
|---|---|---|
| 3-FMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-MMC | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 8-Chlorotheophylline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Adrafinil | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Anandamide | Caution | Cannabis can unpredictably intensify psychedelic effects and increase anxiety |
| Cannabis | Uncertain | — |
| 1,3-Butanediol | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 25E-NBOH | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T-2 | Low Risk & Synergy | Cross-tolerance exists; effects compound |
History
Development and PiHKAL
2C-E was synthesized by Alexander Shulgin as part of his 4-substituted 2,5-dimethoxyphenethylamine program. The 4-ethyl substitution represented one of several alkyl variants explored alongside the halogen series. Shulgin's PiHKAL (1991) describes 2C-E as producing "a full and deep psychedelic experience" with "a more profound impact than any of the other 2C compounds at similar doses" — language that established 2C-E's reputation in the psychedelic community before the compound was widely available.
Research Chemical Era
2C-E became commercially available from research chemical vendors in the early 2000s, gaining a reputation as the "serious" 2C compound compared to the more recreational character of 2C-B or 2C-I. Its longer duration, deeper cognitive character, and lower recreational appeal meant it remained primarily within the experiential psychedelic community rather than party circuits.
Music and Subculture
A notable community association developed between 2C-E and analytical musical appreciation. Forum discussions on Reddit, Erowid, and Bluelight consistently describe 2C-E as transformative for hearing music — particularly complex genres (jazz, classical, progressive rock) where harmonic relationships become unusually apparent. This reputation contributed to the compound being specifically sought by musically-oriented users.
Legal Status
2C-E was explicitly scheduled in the United States as a Schedule I substance under the Synthetic Drug Abuse Prevention Act of 2012, which broadly scheduled multiple 2C and NBOMe compounds. It is controlled in most European jurisdictions and under international conventions.
Harm Reduction
Respect the Reputation
2C-E is not recommended as a first 2C compound. Significant experience with milder psychedelics — and preferably with 2C-B or 2C-C — is a sensible prerequisite. The intellectually demanding character can be profoundly rewarding for prepared users but disorienting for the unprepared.
Dose Carefully
- Threshold: 5–10 mg | Common: 15–20 mg | Strong: 20–25 mg | Heavy: 25+ mg
- The step from 20 to 25 mg represents a meaningful qualitative jump in intensity
- Measure with a precision milligram scale
Prepare for Nausea
Nausea during the come-up (45–120 minutes) is common and predictable. Practical strategies endorsed by the community:
- Dose on a light or empty stomach
- Have fresh ginger tea or ginger candies available
- Prepare for possible vomiting; it does not represent a medical emergency and typically resolves as effects develop
Set and Setting
2C-E rewards intentional preparation more than most psychedelics. Given its tendency to surface emotional and psychological depth, approach it with a specific intention, in a setting that supports introspection. Nature settings and extended time windows (the full 10 hours) are frequently cited by community members as ideal.
Duration
Allow the full day. Do not schedule obligations within 12 hours of dosing.
Avoid Cannabis
More than with other 2C compounds, the community consistently flags cannabis as a risk factor for difficult 2C-E experiences. Reserve this combination for highly experienced users who know their reaction.
Toxicity & Safety
General Safety Profile
2C-E has no reported fatalities attributable directly to its pharmacological action. However, it carries the full complement of psychological risks associated with potent, long-duration psychedelics, and its demanding character means these risks are clinically relevant.
Nausea and GI Effects
Nausea is common during the come-up phase (45–120 minutes post-dosing) and is one of the most frequently reported adverse effects. Vomiting occurs in some users at higher doses. The physiological mechanism is unclear; it generally resolves as the psychedelic state develops.
Cardiovascular
Mild sympathomimetic effects (tachycardia, elevated blood pressure, pupil dilation) are expected based on the phenethylamine structure. These are typically moderate at common doses but become more significant at higher doses or in combination with stimulants.
Psychological Risks
The intellectually demanding and emotionally penetrating character of 2C-E makes it particularly likely to surface unresolved psychological material. Difficult experiences involving confrontation with personal fears, grief, or existential themes are more common than with more visually-oriented psychedelics like 2C-B. Users with unstable mental health or who are navigating acute life crises should not use 2C-E.
Duration Risk
The 6–10 hour duration represents a commitment. A difficult experience will persist longer than most other psychedelics. Benzos remain the reliable pharmacological intervention if the experience becomes medically urgent.
Drug Interactions
Addiction Potential
Not physically addictive. Like other psychedelics, rapid tolerance development limits compulsive use. No withdrawal syndrome. Low abuse liability.
Overdose Information
Fatal overdose from 2C-E alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.
However, psychological emergencies can occur and require appropriate response:
- Severe anxiety, panic, or psychotic episodes
- Dangerous behavior due to impaired reality testing
- Self-harm in the context of a distressing experience
Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.
Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.
Tolerance
| Full | Develops almost immediately after ingestion |
| Half | 3 days |
| Zero | 7 days |
Cross-tolerances
Legal Status
Regulatory Status
United States
2C-E (2,5-dimethoxy-4-ethylphenethylamine) is a Schedule I controlled substance in the United States. It was placed into Schedule I through theSynthetic Drug Abuse Prevention Act of 2012, signed into law on July 9, 2012 as part of the FDA Safety and Innovation Act (S. 3187). This legislation permanently scheduled nine 2C-series phenethylamines alongside 15 synthetic cannabinoids and two synthetic cathinones . Prior to 2012, 2C-E was prosecutable under theFederal Analogue Act as a structural analogue of the already-scheduled 2C-B (Schedule I since 1995), but the explicit scheduling eliminated any ambiguity.
International Status
- United Kingdom: Controlled as aClass A substance under the Misuse of Drugs Act 1971. The 2C series phenethylamines are captured under the generic definition covering ring-substituted phenethylamines.
- Germany: Scheduled underAnlage I of the Betaubungsmittelgesetz (BtMG), the most restrictive category prohibiting all handling without specific authorization.
- Canada: Controlled underSchedule III of the Controlled Drugs and Substances Act, which broadly covers 2,5-dimethoxyphenethylamine derivatives.
- Australia: Listed inSchedule 9 of the Poisons Standard as a prohibited substance.
- Japan: Controlled as a designated substance under the Pharmaceutical and Medical Device Act.
- Netherlands: Despite the Netherlands' relatively permissive drug policy, 2C-E is listed onList I of the Opium Act (Opiumwet), the most restrictive category .
References
Synthetic Drug Abuse Prevention Act of 2012, S. 3190, 112th Congress. Pub. L. 112-144, Title XI, section 1152. EMCDDA. European Drug Report: phenethylamine derivatives legal status overview.
Experience Reports (2)
Tips (8)
Keep a benzodiazepine like alprazolam on hand as an emergency trip abort tool when using 2C-E. Even just knowing you have one available provides psychological reassurance. It will not fully end the trip but significantly reduces intensity.
Do not combine 2C-E with lithium (seizure risk), tramadol (seizure/serotonin syndrome risk), or cannabis at higher doses unless very experienced. Cannabis dramatically intensifies and can destabilize a psychedelic experience.
2C-E has a reputation for being less predictable and more intense than 2C-B, with a steeper dose-response curve. The difference between 15mg and 25mg can be dramatic. Always use a milligram scale and volumetric dosing, and increase doses in small 3-5mg increments.
2C-E is considered one of the best psychedelics for music enhancement. At 20-25mg the auditory experience becomes extraordinarily immersive, with many describing their entire body becoming the ultimate sound system. If you love music, this compound is worth exploring.
Significant body load including nausea and stomach discomfort is common with 2C-E, especially during the come-up which can last over an hour. Having ginger and anti-nausea remedies ready is advisable. The discomfort typically resolves once the peak is reached.
Use a milligram scale to weigh 2C-E if it comes as a powder. Eyeballing doses of potent psychedelics is irresponsible. A quality 0.001g scale costs under $30 and could prevent a seriously overwhelming experience.
Community Discussions (2)
See Also
References (4)
- Psilocybin produces substantial and sustained decreases in depression and anxiety — Griffiths et al. Journal of Psychopharmacology (2016)paper
- Neural correlates of the LSD experience revealed by multimodal neuroimaging — Carhart-Harris et al. PNAS (2016)paper
- 2C-E - TripSit Factsheet
TripSit factsheet for 2C-E
tripsit - 2C-E - Wikipedia
Wikipedia article on 2C-E
wikipedia